Human Umbilical Cord Blood Derived (HUCB) Mesenchymal Stem Cells (MSc’s) As an Alternative Therapeutics in Managing Infections

Authors

  • Madhushree R
  • Jolitha A.B
  • Ranjitha A
  • Smitha N
  • Manjula K R

DOI:

https://doi.org/10.63682/jns.v14i13S.4859

Keywords:

UCB, MSCs, stem cells, Umbilical cord

Abstract

Umbilical cord blood (UCB), considered medical waste, contains Mesenchymal stem cells (MSCs) in a mucous connective tissue known as Wharton’s jelly. These cells exhibit the ability to self-renew and maintain multipotency while differentiating into various lineages. UCB provides a non-invasive and ethically uncomplicated source for MSC and UC-derived MSCs (UC-MSCs) are particularly valuable due to their immunomodulatory properties, making them promising candidates for regenerative medicine and immunotherapy.

This study aims to explore the current understanding of UC-MSCs, their differentiation potential, clinical applications, and the challenges faced in MSC therapy. The emergence of mesenchymal stem cells (MSCs) as a potential antimicrobial agent was also done. An attempt to optimize the culture conditions, cell sourcing, and standardization of protocols to maximize their therapeutic efficacy.

Downloads

Download data is not yet available.

References

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 Apr 2;284(5411):143-7. doi: 10.1126/science.284.5411.143. PMID: 10102814.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905. PMID: 16923606.

Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008 Mar;26(3):591-9. doi: 10.1634/stemcells.2007-0439. Epub 2007 Dec 6. PMID: 18065397; PMCID: PMC3311226.

El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev. 2014 Oct;20(5):523-44. doi: 10.1089/ten.TEB.2013.0664. Epub 2014 Apr 22. PMID: 24552279.

Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006 May;24(5):1294-301. doi: 10.1634/stemcells.2005-0342. Epub 2006 Jan 12. PMID: 16410387.

Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012 Apr 25;12(5):383-96. doi: 10.1038/nri3209. PMID: 22531326.

Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013 Jun;34(6):747-54. doi: 10.1038/aps.2013.50. PMID: 23736003; PMCID: PMC4002895.

Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14. PMID: 26016486; PMCID: PMC4451395.

Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998 Aug 20;339(8):520-32. doi: 10.1056/NEJM199808203390806. PMID: 9709046.

Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol. 2014 Feb;17:32-7. doi: 10.1016/j.mib.2013.11.004. Epub 2013 Dec 10. PMID: 24581690; PMCID: PMC3942668.

Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005 Dec;3(12):948-58. doi: 10.1038/nrmicro1289. PMID: 16322743.

Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009 Sep;7(9):629-41. doi: 10.1038/nrmicro2200. PMID: 19680247; PMCID: PMC2871281.

Fowler VG Jr, Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect. 2014 May;20 Suppl 5(0 5):66-75. doi: 10.1111/1469-0691.12570. PMID: 24476315; PMCID: PMC4067250.

Le Blanc, K., & Pittenger, M. F. (2005). Mesenchymal stem cells: progress toward promise. Cytotherapy, 7(1), 36–45. https://doi.org/10.1080/14653240510018118

Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008 Sep;8(9):726-36. doi: 10.1038/nri2395. PMID: 19172693.

Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noël D, Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003 Nov 15;102(10):3837-44. doi: 10.1182/blood-2003-04-1193. Epub 2003 Jul 24. PMID: 12881305.

Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003;21(1):50-60. doi: 10.1634/stemcells.21-1-50. Erratum in: Stem Cells. 2003;21(2):247. PMID: 12529551.

Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells. 2008 Mar;26(3):591-9. doi: 10.1634/stemcells.2007-0439. Epub 2007 Dec 6. PMID: 18065397; PMCID: PMC3311226.

Ahmadi M, Seyedjafari E, Zargar SJ, Birhanu G, Zandi-Karimi A, Beiki B, Tuzlakoglu K. Osteogenic differentiation of mesenchymal stem cells cultured on PLLA scaffold coated with Wharton's Jelly. EXCLI J. 2017 May 23;16:785-794. doi: 10.17179/excli2016-741. PMID: 28827995; PMCID: PMC5547391.

Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007 Feb;25(2):319-31. doi: 10.1634/stemcells.2006-0286. Epub 2006 Oct 19. PMID: 17053211.

Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005 Feb;23(2):220-9. doi: 10.1634/stemcells.2004-0166. PMID: 15671145.

Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002 Dec;13(12):4279-95. doi: 10.1091/mbc.e02-02-0105. PMID: 12475952; PMCID: PMC138633.

Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell. 2015 Jul 2;17(1):11-22. doi: 10.1016/j.stem.2015.06.007. PMID: 26140604.

Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008 Jun 1;46 Suppl 5(Suppl 5):S350-9. doi: 10.1086/533591. PMID: 18462090; PMCID: PMC2474459.

Baksh, Dolores & Song, Lin & Tuan, Rocky. (2004). Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. Journal of cellular and molecular medicine. 8. 301-16. 10.1111/j.1582-4934.2004.tb00320.x.

Downloads

Published

2025-04-29

How to Cite

1.
Madhushree R MR, A.B J, Ranjitha A RA, Smitha N SN, K R M. Human Umbilical Cord Blood Derived (HUCB) Mesenchymal Stem Cells (MSc’s) As an Alternative Therapeutics in Managing Infections. J Neonatal Surg [Internet]. 2025 Apr. 29 [cited 2026 May 30];14(13S):1274-81. Available from: https://jneonatalsurg.com/index.php/jns/article/view/4859